Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 08, 2020 |
referred to ways and means |
Jan 23, 2019 |
reported referred to ways and means |
Jan 09, 2019 |
referred to alcoholism and drug abuse |
Assembly Bill A307
2019-2020 Legislative Session
Sponsored By
ROSENTHAL L
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
Albert A. Stirpe
Mike Reilly
John T. McDonald III
2019-A307 (ACTIVE) - Details
2019-A307 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 307 2019-2020 Regular Sessions I N A S S E M B L Y (PREFILED) January 9, 2019 ___________ Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Alcoholism and Drug Abuse AN ACT to amend the mental hygiene law, in relation to requiring the office of alcoholism and substance abuse services to maintain an online directory of distributors of opioid antagonists THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 19.09 of the mental hygiene law is amended by adding a new subdivision (k) to read as follows: (K)(1) THE OFFICE, IN CONSULTATION WITH THE DEPARTMENT OF HEALTH, SHALL MAINTAIN ON ITS WEBSITE A PUBLICLY AVAILABLE DIRECTORY OF ALL DISTRIBUTORS OF OPIOID ANTAGONISTS TO THE PUBLIC, INCLUDING BUT NOT LIMITED TO, PHARMACIES, PREVENTION PROGRAMS AND NOT-FOR-PROFITS. AS USED IN THIS SUBDIVISION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEAN- INGS: (I) "OPIOID" MEANS AN OPIATE AS DEFINED IN SECTION THIRTY-THREE HUNDRED TWO OF THE PUBLIC HEALTH LAW. (II) "OPIOID ANTAGONIST" MEANS A FEDERAL FOOD AND DRUG ADMINISTRA- TION-APPROVED DRUG THAT, WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST SHALL BE LIMITED TO NALOXONE OR OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH FOR THIS PURPOSE. (2) THE DIRECTORY REQUIRED BY THIS SUBDIVISION SHALL INCLUDE AND BE SEARCHABLE BY THE FOLLOWING INFORMATION: (I) ADDRESSES OF EACH DISTRIBUTOR OF OPIOID ANTAGONISTS; (II) CONTACT INFORMATION, SUCH AS PHONE NUMBERS OR EMAIL ADDRESSES, FOR EACH DISTRIBUTOR; (III) SERVICES OFFERED BY EACH DISTRIBUTOR AT EACH LOCATION IF MORE THAN ONE, AS WELL AS INFORMATION PROVIDING WHICH OPIOID ANTAGONISTS ARE CURRENTLY AVAILABLE AT EACH DISTRIBUTOR; EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.